It is proposed that this article be deleted because of the following concern:
If you can address this concern by improving, copyediting, sourcing, renaming, or merging the page, please edit this page and do so. You may remove this message if you improve the article or otherwise object to deletion for any reason. Although not required, you are encouraged to explain why you object to the deletion, either in your edit summary or on the talk page. If this template is removed, do not replace it. The article may be deleted if this message remains in place for seven days, i.e., after 13:45, 26 December 2024 (UTC). Find sources: "Bure Equity" – news · newspapers · books · scholar · JSTORPRODExpired+%5B%5BWP%3APROD%7CPROD%5D%5D%2C+concern+was%3A+Fails+%5B%5BWP%3ANCORP%5D%5D.+Insufficient+independent+in-depth+sources+to+establish+notability.+Tagged+for+multiple+issues+for+years.Expired ], concern was: Fails WP:NCORP. Insufficient independent in-depth sources to establish notability. Tagged for multiple issues for years. |
Another editor has reviewed this page's proposed deletion and endorses both the proposal and the reason given above. If you remove the {{proposed deletion/dated}} tag above, please also remove this {{Proposed deletion endorsed}} tag. |
This article has multiple issues. Please help improve it or discuss these issues on the talk page. (Learn how and when to remove these messages)
|
Bure Equity is a Swedish investment company involved in communications, textiles, training, and education. It is the largest private school operator in Sweden. Bure Equity owns Vittra, a company that runs schools in Sweden and other countries.
On February 11, 2009, Altor Fund III and Bure Equity AB signed an agreement to acquire Carnegie Investment Bank, a leading independent Nordic investment bank, from the Swedish National Debt Office. The total net asset value on 31 December 2016 amounted to six billion kroner and the largest holdings were in the companies Mycronic and Vitrolife. The company also has shares in, among others, the industrial company Cavotec, the pharmaceutical company MedCap, the medical technology company Xvivo Perfusion and the auction company Lauritz.com.
Henrik Blomquist took over as CEO in 2014.
On 20 January, 2022, Bure sold their locomotive leasing business for an undisclosed amount.
References
- Corporate Information Snapshot Archived July 8, 2011, at the Wayback Machine
- Embracing private schools Washington Times August 11, 2008
- "Bure - press release". Cision Wire. Archived from the original on 2012-07-30. Retrieved 2009-02-11.
- "Bure - Finansiella rapporter". www.bure.se. Retrieved 2022-07-25.
- "Blomquist utsedd till vd i Bure | Affärsvärlden". 2018-07-20. Archived from the original on 2018-07-20. Retrieved 2022-07-25.
- "Bure Equity sells locomotive leasing business". 2022-01-24. Retrieved 2023-11-10.
External links
This Swedish corporation or company article is a stub. You can help Misplaced Pages by expanding it. |
This article about investment is a stub. You can help Misplaced Pages by expanding it. |